Pre-treatment SNOT-22 Score Predicts Response to Endoscopic Polypectomy in Clinic (EPIC) Our experience in 30 adults.
Clin Otolaryngol. 2016 Jan 23;
Authors: Caulley L, Lasso A, Rudmik L, Kilty SJ
Abstract
Endoscopic polypectomy in clinic (EPIC) has demonstrated substantial short-term improvement in patient reported quality of life measures and a pilot economic analysis of EPIC confirmed its cost-effectiveness in comparison to endoscopic sinus surgery. The purpose of this study was to evaluate if pre-treatment Sino Nasal Outcome Tests-22 (SNOT-22) score predicts response to EPIC treatment in parallel to the results found for endoscopic sinus surgery. Depending on the baseline SNOT-22 group the probability of achieving minimal clinically important difference was 75-100% post-EPIC. The relative improvement in quality of life on average was 62% with 90% realising a minimal clinically important difference in their SNOT-22 score. These results are comparable to what has been found for endoscopic sinus surgery. The results of this study reflect the published results of the effect of endoscopic sinus surgery on SNOT-22 scores 6 months post-intervention which themselves have been shown to predict SNOT-22 scores at 18 months post-endoscopic sinus surgery. In select patients with chronic rhinosinusitis with nasal polyps the EPIC procedure may provide SNOT-22 score improvements similar to those seen with patients who undergo endoscopic sinus surgery This article is protected by copyright. All rights reserved.
PMID: 26802485 [PubMed - as supplied by publisher]
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1S34kf9
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου